| Literature DB >> 27471733 |
Jan Matczuk1, Anna Zalewska2, Bartłomiej Łukaszuk3, Małgorzata Knaś4, Mateusz Maciejczyk5, Marta Garbowska6, Dominika M Ziembicka7, Danuta Waszkiel2, Adrian Chabowski3, Małgorzata Żendzian-Piotrowska6, Krzysztof Kurek3.
Abstract
In today's world wrong nutritional habits together with a low level of physical activity have given rise to the development of obesity and its comorbidity, insulin resistance. More specifically, many researches indicate that lipids are vitally involved in the onset of a peripheral tissue (e.g., skeletal muscle, heart, and liver) insulin resistance. Moreover, it seems that diabetes can also induce changes in respect of lipid composition of both the salivary glands and saliva. However, judging by the number of research articles, the salivary glands lipid profile still has not been sufficiently explored. In the current study we aim to assess the changes in the main lipid fractions, namely, triacylglycerols, phospholipids, free fatty acids, and diacylglycerols, in the parotid and the submandibular salivary glands of rats exposed to a 5-week high fat diet regimen. We observed that the high caloric fat diet caused a significant change in the salivary glands lipid composition, especially with respect to PH and TG, but not DAG or FFAs, classes. The observed reduction in PH concentration is an interesting phenomenon frequently signifying the atrophy and malfunctions in the saliva secreting organs. On the other hand, the increased accumulation of TG in the glands may be an important clinical manifestation of metabolic syndrome and type 2 diabetes mellitus.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27471733 PMCID: PMC4951584 DOI: 10.1155/2016/8163474
Source DB: PubMed Journal: J Diabetes Res Impact factor: 4.011
Phospholipids composition in the parotid salivary glands (nmol/g).
| Fatty acid | Control | High fat diet |
|---|---|---|
| Myristic (14:0) | 1067.79 ± 245.404 | 1064.25 ± 183.734 |
| Palmitic (16:0) | 18308.42 ± 3549.057 | 20006.66 ± 3724.717 |
| Palmitoleic (16:1) | 2262.11 ± 752.999 | 1716.34 ± 255.614 |
| Stearic (18:0) | 1666.38 ± 290.83 | 1936.75 ± 250.423 |
| Oleic (18:1) | 3515.13 ± 567.385 | 4726.36 ± 910.837 |
| Linoleic (18:2) | 1920.61 ± 575.49 | 2656.63 ± 432.943 |
| Arachidic (20:0) | 101.46 ± 21.18 | 118.36 ± 36.992 |
|
| 257.25 ± 90.915 | 212.67 ± 30.417 |
| Behenic (22:0) | 167.36 ± 28.941 | 131.77 ± 32.863 |
| Arachidonic (20:4) | 737.81 ± 101.194 | 731.71 ± 123.755 |
| Lignoceric (24:0) | 98.77 ± 18.389 | 120.46 ± 37.501 |
| Eicosapentaenoic (20:5) | 30.46 ± 8.774 | 55.63 ± 8.098 |
| Nervonic (24:1) | 88.62 ± 13.577 | 80.72 ± 19.464 |
| Docosahexaenoic (22:6) | 451.08 ± 69.753 | 614.43 ± 175.756 |
| UFA | 9263.07 ± 971.175 | 10794.47 ± 1410.346 |
| SFA | 21410.18 ± 3888.879 | 23378.25 ± 3956.379 |
| Total | 30673.25 ± 4728.9 | 34172.72 ± 4828.508 |
Results are based on 8 independent preparations for each experimental treatment (means ± SD). p < 0.05 compared with control group.
Phospholipids composition in the submandibular salivary glands (nmol/g).
| Fatty acid | Control | High fat diet |
|---|---|---|
| Myristic (14:0) | 1812.03 ± 410.021 | 220.06 ± 50.003 |
| Palmitic (16:0) | 20700.35 ± 5080.428 | 4084.86 ± 826.012 |
| Palmitoleic (16:1) | 4888.46 ± 1330.273 | 347.52 ± 90.284 |
| Stearic (18:0) | 2551.09 ± 568.847 | 1235.59 ± 228.771 |
| Oleic (18:1) | 15946.36 ± 3926.205 | 4915.29 ± 1193.102 |
| Linoleic (18:2) | 10439.62 ± 3124.438 | 2841.45 ± 698.514 |
| Arachidic (20:0) | 46.67 ± 14.163 | 31.41 ± 3.803 |
|
| 488.17 ± 261.042 | 157.67 ± 37.696 |
| Behenic (22:0) | 51.8 ± 7.359 | 32.97 ± 2.694 |
| Arachidonic (20:4) | 391.03 ± 70.611 | 196.61 ± 18.14 |
| Lignoceric (24:0) | 14.08 ± 3.693 | 12.93 ± 2.181 |
| Eicosapentaenoic (20:5) | 15.41 ± 3.307 | 18.88 ± 1.696 |
| Nervonic (24:1) | 13.09 ± 2.719 | 5.57 ± 0.947 |
| Docosahexaenoic (22:6) | 92.91 ± 26.462 | 38.75 ± 5.619 |
| UFA | 32275.05 ± 6588.666 | 8521.74 ± 1983.94 |
| SFA | 25176.03 ± 5704.184 | 5617.82 ± 1005.162 |
| Total | 57451.08 ± 11482.449 | 14139.56 ± 2787.592 |
Results are based on 8 independent preparations for each experimental treatment (means ± SD). p < 0.05 compared with control group.
Free fatty acids composition in the parotid salivary glands (nmol/g).
| Fatty acid | Control | High fat diet |
|---|---|---|
| Myristic (14:0) | 73.74 ± 11.539 | 38.11 ± 4.69 |
| Palmitic (16:0) | 1225.19 ± 312.786 | 721.51 ± 90.679 |
| Palmitoleic (16:1) | 475.43 ± 90.237 | 87.46 ± 21.989 |
| Stearic (18:0) | 430.62 ± 120.932 | 230.14 ± 43.29 |
| Oleic (18:1) | 369.43 ± 50.221 | 156.9 ± 39.858 |
| Linoleic (18:2) | 337.67 ± 50.205 | 151.54 ± 35.83 |
| Arachidic (20:0) | 6.67 ± 1.861 | 6.25 ± 0.806 |
|
| 31.86 ± 4.276 | 11.21 ± 3.25 |
| Behenic (22:0) | 18.35 ± 4.609 | 4.2 ± 0.822 |
| Arachidonic (20:4) | 558.74 ± 242.799 | 136.16 ± 41.227 |
| Lignoceric (24:0) | 5.3 ± 1.381 | 3.97 ± 0.72 |
| Eicosapentaenoic (20:5) | 28.94 ± 17.181 | 9.99 ± 3.425 |
| Nervonic (24:1) | 3.88 ± 0.962 | 2.15 ± 0.29 |
| Docosahexaenoic (22:6) | 70.78 ± 7.997 | 5.88 ± 1.923 |
| UFA | 1876.72 ± 267.732 | 561.29 ± 134.462 |
| SFA | 1759.88 ± 383.428 | 1004.18 ± 134.206 |
| Total | 3636.6 ± 622.343 | 1565.47 ± 188.869 |
Results are based on 8 independent preparations for each experimental treatment (means ± SD). p < 0.05 compared with control group.
Free fatty acids composition in the submandibular salivary glands (nmol/g).
| Fatty acid | Control | High fat diet |
|---|---|---|
| Myristic (14:0) | 50.36 ± 7.533 | 13.05 ± 2.304 |
| Palmitic (16:0) | 1044.21 ± 293.655 | 136.95 ± 22.83 |
| Palmitoleic (16:1) | 136.64 ± 33.283 | 3.2 ± 0.647 |
| Stearic (18:0) | 673.43 ± 215.344 | 147.14 ± 21.13 |
| Oleic (18:1) | 374.01 ± 68.926 | 21.52 ± 4.774 |
| Linoleic (18:2) | 347.78 ± 77.772 | 11.45 ± 2.765 |
| Arachidic (20:0) | 10.32 ± 2.892 | 5.01 ± 0.88 |
|
| 31.6 ± 11.089 | 1.97 ± 0.495 |
| Behenic (22:0) | 11.71 ± 0.945 | 2.39 ± 0.336 |
| Arachidonic (20:4) | 828.63 ± 332.348 | 5.27 ± 1.259 |
| Lignoceric (24:0) | 3.67 ± 0.97 | 2.53 ± 0.444 |
| Eicosapentaenoic (20:5) | 24.19 ± 6.655 | 1.55 ± 0.656 |
| Nervonic (24:1) | 3.78 ± 0.859 | 1.32 ± 0.417 |
| Docosahexaenoic (22:6) | 46.98 ± 7.058 | 1.1 ± 0.145 |
| UFA | 1793.6 ± 488.952 | 47.38 ± 7.813 |
| SFA | 1793.71 ± 515.048 | 307.07 ± 44.118 |
| Total | 3587.31 ± 959.758 | 354.44 ± 46.163 |
Results are based on 8 independent preparations for each experimental treatment (means ± SD). p < 0.05 compared with control group.
Diacylglycerols composition in the parotid salivary glands (nmol/g).
| Fatty acid | Control | High fat diet |
|---|---|---|
| Myristic (14:0) | 87.79 ± 22.188 | 56.03 ± 7.414 |
| Palmitic (16:0) | 984.94 ± 210.904 | 575.82 ± 94.842 |
| Palmitoleic (16:1) | 184.17 ± 24.947 | 49.8 ± 9.994 |
| Stearic (18:0) | 431.31 ± 101.976 | 200.57 ± 29.904 |
| Oleic (18:1) | 134.86 ± 21.235 | 93.98 ± 12.105 |
| Linoleic (18:2) | 171.37 ± 35.577 | 130.41 ± 16.157 |
| Arachidic (20:0) | 5.98 ± 1.84 | 5.05 ± 0.855 |
|
| 7.31 ± 1.464 | 5.26 ± 0.914 |
| Behenic (22:0) | 12.08 ± 3.819 | 3.79 ± 0.715 |
| Arachidonic (20:4) | 184.27 ± 76.864 | 94.84 ± 19.375 |
| Lignoceric (24:0) | 3.77 ± 1.47 | 3.24 ± 0.514 |
| Eicosapentaenoic (20:5) | 7.5 ± 3.514 | 5.38 ± 0.913 |
| Nervonic (24:1) | 1.26 ± 0.382 | 1.31 ± 0.221 |
| Docosahexaenoic (22:6) | 28.71 ± 5.259 | 5.89 ± 0.927 |
| UFA | 719.47 ± 127.861 | 386.87 ± 51.931 |
| SFA | 1525.87 ± 303.224 | 844.5 ± 99.547 |
| Total | 2245.33 ± 426.18 | 1231.37 ± 128.942 |
Results are based on 8 independent preparations for each experimental treatment (means ± SD). p < 0.05 compared with control group.
Diacylglycerols composition in the submandibular salivary glands (nmol/g).
| Fatty acid | Control | High fat diet |
|---|---|---|
| Myristic (14:0) | 48.38 ± 11.363 | 38.27 ± 7.62 |
| Palmitic (16:0) | 599.62 ± 94.795 | 281.06 ± 47.48 |
| Palmitoleic (16:1) | 58.54 ± 19.612 | 4.72 ± 0.704 |
| Stearic (18:0) | 364.07 ± 54.254 | 261.05 ± 48.843 |
| Oleic (18:1) | 142.47 ± 40.036 | 44.75 ± 5.25 |
| Linoleic (18:2) | 186.84 ± 50.092 | 43.5 ± 5.515 |
| Arachidic (20:0) | 9.04 ± 1.714 | 6.11 ± 0.856 |
|
| 8.62 ± 1.633 | 3.13 ± 0.448 |
| Behenic (22:0) | 7.08 ± 0.724 | 2.94 ± 0.475 |
| Arachidonic (20:4) | 184.5 ± 48.12 | 35.4 ± 3.616 |
| Lignoceric (24:0) | 2.3 ± 0.579 | 2.14 ± 0.393 |
| Eicosapentaenoic (20:5) | 4.65 ± 1.736 | 2.32 ± 0.334 |
| Nervonic (24:1) | 0.75 ± 0.188 | 1.04 ± 0.211 |
| Docosahexaenoic (22:6) | 13.61 ± 2.375 | 2.06 ± 0.324 |
| UFA | 600 ± 134.423 | 136.92 ± 10.521 |
| SFA | 1030.49 ± 155.56 | 591.57 ± 101.192 |
| Total | 1630.49 ± 266.998 | 728.49 ± 107.393 |
Results are based on 8 independent preparations for each experimental treatment (means ± SD). p < 0.05 compared with control group.
Triacylglycerols composition in the parotid salivary glands (nmol/g).
| Fatty acid | Control | High fat diet |
|---|---|---|
| Myristic (14:0) | 95.58 ± 16.557 | 93.13 ± 10.494 |
| Palmitic (16:0) | 3753.26 ± 577.212 | 4106.75 ± 355.387 |
| Palmitoleic (16:1) | 725.82 ± 311.454 | 457.56 ± 60.399 |
| Stearic (18:0) | 1545.87 ± 203.585 | 1739.3 ± 179.592 |
| Oleic (18:1) | 740.19 ± 141.33 | 758.58 ± 60.541 |
| Linoleic (18:2) | 1745.84 ± 508.939 | 2123 ± 239.624 |
| Arachidic (20:0) | 6.46 ± 0.973 | 6.98 ± 1.074 |
|
| 15.69 ± 5.458 | 14.51 ± 3.86 |
| Behenic (22:0) | 57.18 ± 12.029 | 25.77 ± 5.108 |
| Arachidonic (20:4) | 2336.43 ± 247.191 | 2462.9 ± 323.202 |
| Lignoceric (24:0) | 6.2 ± 1.302 | 7.04 ± 1.189 |
| Eicosapentaenoic (20:5) | 63.45 ± 20.07 | 114.81 ± 19.906 |
| Nervonic (24:1) | 6 ± 3.685 | 4.11 ± 2.077 |
| Docosahexaenoic (22:6) | 175.64 ± 37.506 | 250.05 ± 49.041 |
| UFA | 5809.07 ± 895.885 | 6185.53 ± 508.847 |
| SFA | 5464.55 ± 774.298 | 5978.97 ± 530.721 |
| Total | 11273.62 ± 1662.308 | 12164.5 ± 1031.873 |
Results are based on 8 independent preparations for each experimental treatment (means ± SD). p < 0.05 compared with control group.
Triacylglycerols composition in the submandibular salivary glands (nmol/g).
| Fatty acid | Control | High fat diet |
|---|---|---|
| Myristic (14:0) | 72.45 ± 10.702 | 47.77 ± 3.466 |
| Palmitic (16:0) | 2978.17 ± 381.425 | 2979.54 ± 157.422 |
| Palmitoleic (16:1) | 183.65 ± 28.609 | 67.47 ± 4.61 |
| Stearic (18:0) | 1575.82 ± 255.862 | 2004.72 ± 79.831 |
| Oleic (18:1) | 732.15 ± 62.753 | 953.72 ± 35.941 |
| Linoleic (18:2) | 1416.05 ± 347.755 | 2068.17 ± 272.292 |
| Arachidic (20:0) | 14.95 ± 4.395 | 19.21 ± 3.536 |
|
| 15.17 ± 5.569 | 14.62 ± 1.299 |
| Behenic (22:0) | 31.32 ± 9.904 | 28.75 ± 5.13 |
| Arachidonic (20:4) | 2542.74 ± 561.505 | 2542.69 ± 176.752 |
| Lignoceric (24:0) | 15.01 ± 1.78 | 12.17 ± 1.746 |
| Eicosapentaenoic (20:5) | 40.37 ± 13.144 | 95.49 ± 20.396 |
| Nervonic (24:1) | 9.62 ± 4.199 | 6.56 ± 1.041 |
| Docosahexaenoic (22:6) | 171.85 ± 52.848 | 239.27 ± 29.357 |
| UFA | 5111.61 ± 933.047 | 5988 ± 227.362 |
| SFA | 4687.72 ± 623.025 | 5092.15 ± 206.762 |
| Total | 9799.33 ± 1548.921 | 11080.15 ± 422.14 |
Results are based on 8 independent preparations for each experimental treatment (means ± SD). p < 0.05 compared with control group.
Figure 1Effects of high fat diet feeding on the salivary glands lipid profile ((a) parotid salivary glands; (b) submandibular salivary glands). Ctrl: control group (n = 8); DG: diacylglycerols; FFAs: free fatty acids; HFD: high fat diet fed group (n = 8); PH: phospholipids; PSG: parotid salivary glands; SMSG: submandibular salivary glands; TG: triacylglycerols; ∗: difference versus Ctrl (p < 0.05).
Effect of high fat diet feeding on body weight, fasting serum glucose level, fasting serum insulin level, the Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) index, and serum FFA level (measured at the beginning of the 6th week).
| C | HFD | |
|---|---|---|
| Body weight (g) | 315.6 ± 17.0 | 375.4 ± 18.1 |
| Glucose level (mg/dL) | 101.3 ± 6.4 | 164.5 ± 12.4 |
| Insulin level ( | 4.6 ± 0.6 | 55.7 ± 5.7 |
| HOMA-IR | 1.6 ± 1.1 | 20.0 ± 2.5 |
| FFA level ( | 88.6 ± 10.4 | 152.4 ± 10.1 |
C: control group. HFD: group fed with high fat diet.
Results are based on 8 independent preparations for each experimental treatment (means ± SD).
p < 0.05 compared with C group.